Transactions
18
Insider / Alkermes plc.
Jackson Blair Curtis
President & CEO, Alkermes plc at Alkermes plc.
- Company
- Alkermes plc.
- Ticker
- ALKS
- First filing on record
- February 6, 2026
- Latest trade on record
- August 5, 2026
- SEC filings
- EDGAR ↗
Jackson Blair Curtis, President & CEO, Alkermes plc at Alkermes plc., has disclosed 18 transactions in ALKS since February 6, 2026: 0 purchases (0 open-market buys) and 5 sales, worth about $782K at the reported prices. The latest was filed August 7, 2026, 2 days after the trade.
Open-market buys
0
Sales
5
Avg. disclosure lag
1.6d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Jackson Blair Curtis made no purchases and 5 sales worth $782K, plus 13 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Jackson Blair Curtis has traded 1 stock on record; the largest by dollars is ALKS.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 8 | 70,514 | — |
| A | Grant or award | 5 | 385,322 | — |
| F | Shares withheld for tax | 5 | 24,127 | $782K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 18 | 0 | 5 · $782K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | Other A | August 5, 2026 | August 7, 2026 | 2d | 124,305 | — | — | derivative | Form 4 ↗ | |
| ALKS | Other A | August 5, 2026 | August 7, 2026 | 2d | 93,229 | — | — | derivative | Form 4 ↗ | |
| ALKS | Other A | March 2, 2026 | March 4, 2026 | 2d | 44,078 | — | — | derivative | Form 4 ↗ | |
| ALKS | Other A | March 2, 2026 | March 4, 2026 | 2d | 94,900 | — | — | derivative | Form 4 ↗ | |
| ALKS | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 8,322 | — | — | derivative | Form 4 ↗ | |
| ALKS | Sell F | February 26, 2026 | February 27, 2026 | 1d | 3,695 | $31 | $114K | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 8,322 | — | — | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 23, 2026 | February 25, 2026 | 2d | 8,738 | — | — | derivative | Form 4 ↗ | |
| ALKS | Sell F | February 23, 2026 | February 25, 2026 | 2d | 3,880 | $32 | $125K | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 23, 2026 | February 25, 2026 | 2d | 8,738 | — | — | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 19, 2026 | February 20, 2026 | 1d | 9,300 | — | — | derivative | Form 4 ↗ | |
| ALKS | Option / conversion M | February 18, 2026 | February 20, 2026 | 2d | 8,897 | — | — | derivative | Form 4 ↗ | |
| ALKS | Sell F | February 19, 2026 | February 20, 2026 | 1d | 4,130 | $32 | $132K | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 19, 2026 | February 20, 2026 | 1d | 9,300 | — | — | Form 4 ↗ | ||
| ALKS | Sell F | February 18, 2026 | February 20, 2026 | 2d | 3,796 | $32 | $122K | Form 4 ↗ | ||
| ALKS | Option / conversion M | February 18, 2026 | February 20, 2026 | 2d | 8,897 | — | — | Form 4 ↗ | ||
| ALKS | Sell F | February 5, 2026 | February 6, 2026 | 1d | 8,626 | $34 | $289K | Form 4 ↗ | ||
| ALKS | Other A | February 5, 2026 | February 6, 2026 | 1d | 28,810 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 7, 2026 | Form 4 | 0001520262-26-000113 | 2 | published | EDGAR ↗ |
| March 4, 2026 | Form 4 | 0001520262-26-000059 | 2 | published | EDGAR ↗ |
| February 27, 2026 | Form 4 | 0001520262-26-000047 | 3 | published | EDGAR ↗ |
| February 25, 2026 | Form 4 | 0001520262-26-000035 | 3 | published | EDGAR ↗ |
| February 20, 2026 | Form 4 | 0001520262-26-000027 | 6 | published | EDGAR ↗ |
| February 6, 2026 | Form 4 | 0001520262-26-000017 | 2 | published | EDGAR ↗ |
Other insiders at Alkermes plc.
- Hopkinson Craig C. EVP R&D, Chief Medical Officer 58 rows
- Gaffin David Joseph EVP, CLO, Alkermes, Inc. 25 rows
- Parisi Samuel Joseph VP, Finance (Interim PAO) 20 rows
- Nichols Christian Todd SVP, Chief Commercial Officer 19 rows
- snyderman nancy lynn MD Director 10 rows
- Cooke Shane Director 9 rows
- Whitaker Anne Clem Director 9 rows
- Lurker Nancy Director 8 rows
- Wilson Frank Anders Director 8 rows
- Reed Joshua SVP, Chief Financial Officer 7 rows
Everyone on file, with contracts and lobbying under the company's name: Alkermes plc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 6 | 18 | February 6, 2026 | August 7, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.